BLIS Technologies Limited logo

Changes in BLIS Board

Director Appointment8 February 2026BLTConsumer Staples

BLIS Technologies Limited
399 Moray Place, Dunedin, New Zealand, 9016

blis.co.nz info@blis.co.nz


9 February 2026


Changes in BLIS Board


Paul Munro to join the board


The Board of BLIS Technologies Limited is pleased to announce the appointment of Paul Munro as an

Independent Non-Executive Director of the company. Paul’s appointment is effective from 1 March

2026.


Paul has extensive governance experience from a wide range of public and private entities. Prior to

his governance career Paul spent 24 years with Deloitte as a Corporate Finance Partner, primarily

working with large corporates, leading projects and M&A assignments. Following his time with

Deloitte Paul was CEO for Christchurch City Holdings Limited, the holding company for Christchurch

City’s $4 billion investment portfolio.


Paul is currently an Independent Non-Executive Director of Scales Corporation Limited, where he is

Chair of the Audit & Risk Management Committee and New Zealand King Salmon Limited, where he

is also Chair of the Audit, Finance, Risk and Project Development Committee. In addition to this role,

Paul is currently Chair or a Director of a number of private companies, including Chair of Orion New

Zealand Limited, Tait International Limited and Cambridge Partners Limited.


BLIS’ Chair Alison Stewart, said “We are excited to welcome Paul to the BLIS Board. Paul brings

extensive financial, commercial and governance experience from a wide range of businesses. His

skills and experience make him a great replacement and he will be a valuable addition to the Board.


In accordance with BLIS’ constitution, Paul will retire from office at the next BLIS Annual

Shareholders’ Meeting and will be eligible for election at that meeting. In accordance with Listing

Rule 2.6.1, the Board has determined that Paul will be an Independent Director.



Retirement of Geoff Plunket


As advised to the market in September 2025, Geoff Plunket signalled his intention to stand down

from the Board once a replacement had been secured.


Geoff will retire on 1 March 2026 after approximately eight years on the Board, including four and a

half years as Chair.

“Geoff has driven the business’ focus on clear strategic growth initiatives and their delivery. Having

also strengthened governance and commercial prioritisation, the company is well positioned to

capitalise on the growing global probiotics market. We wish Geoff all the best in his retirement.“ said

Chair, Dame Alison Stewart.



Ends




BLIS Technologies Limited

399 Moray Place, Dunedin, New Zealand, 9016

blis.co.nz info@blis.co.nz

For further information, please contact:


Alison Stewart

Chair

+64 27 550 0558



About BLIS Technologies Ltd


Delivering proven health benefits through evidence-based, advanced probiotics

BLIS Technologies is an NZX-listed manufacturer of advanced probiotic strains that go beyond the gut.

Combining innovation with evidence-based research and the highest quality production controls enables

the delivery of probiotic solutions for specific health targets including throat health, halitosis (bad breath),

immune support, teeth and gum health and skin health. BLIS

®

products are sold throughout New Zealand

and in Asia, Europe and the USA. More information about BLIS Technologies Ltd can be found at

www.blis.co.nz.


Website: www.blis.co.nz

Instagram: @blisprobiotics #blisk12 #blism18 #blisq24

Facebook: @BLISProbiotics

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.